Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FBIO | AMGN | BMY | GILD | VRTX |
| Company | Fortress Biotech Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.6700 | 335.15 | 49.29 | 83.26 | 474.36 |
| High | 1.6700 | 338.19 | 49.53 | 83.76 | 474.93 |
| Low | 1.4201 | 334.27 | 49.06 | 82.75 | 467.92 |
| Last | 1.4800 | 336.36 | 49.23 | 83.14 | 468.53 |
| Change | -0.3600 | +0.41 | +0.21 | -0.76 | -9.37 |
| % Change | -19.57% | +0.12% | +0.43% | -0.91% | -1.96% |
| Volume | 4,240,918 | 1,329,767 | 7,190,981 | 4,627,527 | 533,154 |
| 20-Day Average Volume | 417,780 | 1,715,325 | 8,465,288 | 6,621,241 | 957,223 |
| Previous Close | 1.8400 | 335.95 | 49.02 | 83.90 | 477.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9032 | 330.16 | 49.17 | 80.45 | 479.34 |
| 20-Day Raw Stochastic | 6.07% | 85.42% | 55.34% | 83.41% | 22.07% |
| 20-Day Relative Strength | 33.95% | 57.77% | 55.05% | 69.33% | 45.19% |
| Weighted Alpha | -56.29 | +27.16 | -10.64 | +17.27 | +30.23 |
| Today's Opinion | 56% Sell | 96% Buy | 72% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 56% Sell | 96% Buy | 56% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 24% Buy | 88% Buy | 40% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -25.63% since 09/13/24 | +1.09% since 09/13/24 | +0.23% since 09/13/24 | +0.71% since 09/13/24 | -3.29% since 09/13/24 |
| Low | 1.4201 on 09/20/24 | 331.00 on 09/18/24 | 48.78 on 09/18/24 | 82.38 on 09/17/24 | 467.92 on 09/20/24 |
| High | 2.0400 on 09/18/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | -24.87% since 08/20/24 | +2.29% since 08/20/24 | +0.54% since 08/20/24 | +11.57% since 08/20/24 | -3.68% since 08/20/24 |
| Low | 1.4201 on 09/20/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.80 on 08/21/24 | 460.69 on 09/11/24 |
| High | 2.1599 on 08/27/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | -14.33% since 06/20/24 | +8.45% since 06/20/24 | +19.99% since 06/20/24 | +21.77% since 06/20/24 | -0.42% since 06/20/24 |
| Low | 1.4201 on 09/20/24 | 306.11 on 07/03/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 458.04 on 08/13/24 |
| High | 2.8900 on 07/23/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | -23.30% since 03/20/24 | +23.09% since 03/20/24 | -5.08% since 03/20/24 | +12.73% since 03/20/24 | +13.91% since 03/20/24 |
| Low | 1.4201 on 09/20/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 2.8900 on 07/23/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 37,558 | 180,215,344 | 99,368,440 | 104,527,072 | 123,323,528 |
| Shares Outstanding, K | 20,412 | 536,435 | 2,027,100 | 1,245,853 | 258,053 |
| Annual Sales | 84,510,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -60,640,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 14,900,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -10,950,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.81 | 0.61 | 0.46 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 08/13/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/12/24 | 10/29/24 | 10/31/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 36.31 | 17.85 | 0.00 |